Understand the source comparison
Best Peptides for Migraine Prevention: Research-Grade Comparison
Cerebrolysin Neurotrophic factor upregulation, reduced excitotoxicity TrkB (BDNF receptor), NMDA modulation IV infusion (clinical), SC (research models) −20°C lyophilised, 2–8°C reconstituted (14 days) Used in stroke, TBI. Migraine application preclinical Thym
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Cerebrolysin
- Neurotrophic factor upregulation, reduced excitotoxicity
- TrkB (BDNF receptor), NMDA modulation
- IV infusion (clinical), SC (research models)
- −20°C lyophilised, 2–8°C reconstituted (14 days)
- Used in stroke, TBI. Migraine application preclinical
- Thymalin
- T-cell regulation, reduced neuroinflammation
- Thymulin receptor on T-lymphocytes
- Subcutaneous injection
- −20°C to −80°C, reconstitute immediately before use
- Immunomodulation research. Migraine hypothesis based on inflammation link
- Dihexa
- HGF mimetic, blood-brain barrier stabilisation, synaptogenesis
- c-Met receptor on neurons and endothelium
- Oral (with enhancers) or SC
- −20°C lyophilised, 2–8°C reconstituted (28 days)
- Cognitive enhancement models. Vascular stabilisation relevant to migraine